Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Iambic Therapeutics announced it raised $66 Million in an initial filing from an offering of $66.5 Million
PRIVATESep 09, 2026•about 2 hours ago
Amount Raised
$66 Million
Round Type
Venture - Series Unknown
San DiegoBiotechnology
Company Information
Company
Iambic Therapeutics
Location
5627 OBERLIN DRIVE, SUITE 120
San Diego, California, United States
About
Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, both internally and in partnership, to address urgent unmet patient need.
Don't miss Iambic Therapeutics's next move
Get an email the moment Iambic Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
2 contacts
Verified contactsFred M., Co-founder and CTO hidden hidden
Predictive Intelligence
Strategic
ML-powered predictions for Iambic Therapeutics's next move
San DiegoBiotechnology